Innervace Raises $40M in Funding for Novel Parkinson’s Cell Therapy
Biotech company Innervace — a spinoff from the University of Pennsylvania — has raised up to $40 million to support the development of its novel regenerative cell therapy platform for Parkinson’s disease. Innervace’s cell therapy platform specifically aims to create implantable tissue to replace the lost neuronal circuits…